Trends in <scp>FDA Transporter‐Based</scp> Post‐Marketing Requirements and Commitments Over the Last Decade-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Trends in FDA Transporter‐Based Post‐Marketing Requirements and Commitments Over the Last Decade

Published:2022-08-06 Issue:3 Volume:112 Page:635-642
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin Pharma and Therapeutics

Author:

Younis Islam R.¹^ORCID,Manchandani Pooja²,Hassan Hazem E.³,Qosa Hisham⁴

Affiliation:

1. Department of Clinical Pharmacology Gilead Sciences, Inc. Foster City California USA

2. Clinical Pharmacology and Exploratory Development Astellas Pharma Global Development, Inc. Northbrook Illinois USA

3. School of Pharmacy University of Maryland Baltimore Maryland USA

4. Bristol Myers Squibb Princeton New Jersey USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2701

Reference29 articles.

1. Membrane transporters in drug development

2. Analysis of Drug-Drug Interaction Labeling Language and Clinical Recommendations for Newly Approved Drugs Evaluated With Digoxin, Midazolam, and S-Warfarin

3. Drug Disposition and Drug-Drug Interaction Data in 2013 FDA New Drug Applications: A Systematic Review

4. Key Findings from Preclinical and Clinical Drug Interaction Studies Presented in New Drug and Biological License Applications Approved by the Food and Drug Administration in 2014

5. Pharmacokinetic Drug-Drug Interactions with Drugs Approved by the US Food and Drug Administration in 2020: Mechanistic Understanding and Clinical Recommendations

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics–Pharmacodynamics Modeling for Evaluating Drug–Drug Interactions in Polypharmacy: Development and Challenges;Clinical Pharmacokinetics;2024-06-18

2. A descriptive analysis of postmarketing requirement studies and clinical trials;Pharmacoepidemiology and Drug Safety;2023-11-23

3. Involvement of Transporters in Intestinal Drug–Drug Interactions of Oral Targeted Anticancer Drugs Assessed by Changes in Drug Absorption Time;Pharmaceutics;2022-11-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3